Company news
Dermata Therapeutics, Inc. news in 2023
Dermata Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
December 19, 2023
Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols
November 15, 2023
Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
November 15, 2023
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 8, 2023
Dermata to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 30, 2023
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 9, 2023
Dermata Therapeutics Announces Positive Feedback from FDA on the DMT310 Phase 3 Clinical Development Program in Moderate-to-Severe Acne
June 26, 2023
Dermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9: 00 A.M. ET
June 12, 2023
Journal of the American Academy of Dermatology Publishes Positive DMT310 Phase 2b Acne Results
June 7, 2023
Dermata Therapeutics Announces Closing of $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
May 25, 2023
Dermata Therapeutics Announces $1.8 Million Offering Priced At-The-Market Under Nasdaq Rules
May 23, 2023
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 10, 2023
Dermata Announces Receipt of Type C Meeting Response from the FDA and Submission of DMT310 End of Phase 2 Meeting Package
April 19, 2023
Dermata Therapeutics Announces Closing of $5.0 Million Public Offering
March 19, 2023
Dermata Therapeutics Announces Pricing of $5.0 Million Public Offering
March 15, 2023
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Results
February 20, 2023